Company: BBVXF
Filing Date: 2025-01-08
Form Type: 424B5
Source: 0001193125-25-003393
Chunk: 19

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-01-08
Form: 424B5
Chunk 19
---
 comply with, any applicable laws, regulations or regulatory guidance with respect to any resale of the Preferred Securities (or any beneficial interests therein), including the Regulations. Where acting as agent on behalf of a disclosed or undisclosed client when purchasing, or making or accepting an offer to purchase, any Preferred Securities (or any beneficial interests therein) from BBVA and/or the underwriters, all the foregoing representations, warranties, agreements and undertakings will be given by and be binding upon both the agent and its underlying client. Product Classification Pursuant to Section 309B of the Securities and Futures Act 2001 of Singapore, as modified or amended from time to time In connection with Section 309B of the SFA and the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore (the “ CMP Regulations 2018”), BBVA has determined the classification of the Preferred Securities as prescribed capital markets products (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in the Monetary Authority of Singapore (the “ MAS”) Notice SFA 04-N12:Notice on the Sale of Investment Products and the MAS Notice FAA-N16:Notice on Recommendations on Investment Products). S-8

ABOUT THIS PROSPECTUS SUPPLEMENT

You should rely only on the information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus. We and the underwriters have not authorized anyone to provide you with different information.

This prospectus supplement,
or the information incorporated by reference in this prospectus supplement, may add, update or change information in the accompanying prospectus. If information in this prospectus supplement, or the information incorporated by reference in this
prospectus supplement, is inconsistent with the accompanying prospectus, this prospectus supplement, or the information incorporated by reference in this prospectus supplement, will apply and will supersede that information in the accompanying
prospectus.

We are offering the Preferred Securities for sale in those jurisdictions in the United States and elsewhere where it is
lawful to make such offers. The distribution of this prospectus supplement and the accompanying prospectus and the offering of the Preferred Securities in some jurisdictions may be restricted by law. See “Notice to Investors—Restrictions on Marketing and Sales” and “Notice to Investors—Prohibition on Marketing and Sales to Retail Investors”. If you possess this prospectus supplement and the accompanying prospectus, you
should find out about and observe these restrictions. This prospectus supplement and the accompanying prospectus are not an offer to sell the